Fig. 4: Analysis of the GO pathway enrichment for the differentially expressed proteins in NORCSDS and NORIMI with the fold change (greater than 1.2 fold or less than 0.833 fold) and p < 0.05. | Translational Psychiatry

Fig. 4: Analysis of the GO pathway enrichment for the differentially expressed proteins in NORCSDS and NORIMI with the fold change (greater than 1.2 fold or less than 0.833 fold) and p < 0.05.

From: Quantitative proteomics combined independent PRM analysis reveals the mitochondrial and synaptic mechanism underlying norisoboldine’s antidepressant effects

Fig. 4

A The GO analysis for differential proteins of NORCSDS. B The GO analysis for differential proteins of NORIMI. The top 10 most significant enriched entries in the three categories, including biological process (GO-BP), cellular component (GO-CC), and molecular function (GO-MF). The terms in the same category are sorted using the p value.

Back to article page